Granulomatous amoebic encephalitis laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
==Overview==
==Overview==


Balamuthia Granulomatous Amebic Encephalitis (GAE) is a serious infection of the brain and spinal cord caused  by Balamuthia[1,2,3,4]. GAE is often diagnosed only after death. However, it can be diagnosed by examining blood, cerebrospinal fluid, and tissue samples from a living patient as well. Diagnosis of GAE in a living patient is less common because the amebas are difficult  to identify under the microscope, even with commonly used stains[5].
Balamuthia Granulomatous Amebic Encephalitis (GAE) is a serious infection of the [[brain]] and [[spinal cord]] caused  by Balamuthia[1,2,3,4]. GAE is often diagnosed only after death. However, it can be diagnosed by examining [[blood]], [[cerebrospinal fluid]], and tissue samples from a living patient as well. Diagnosis of GAE in a living patient is less common because the amoebas are difficult  to identify under the microscope, even with commonly used stains[5].


However, there are three types  of tests that can help confirm the diagnosis of GAE. The indirect immunofluorescence assay (IFA) is a test used to detect antibodies attached to Balamuthia amebas in body tissues. In contrast, immunohistochemistry (IHC) uses specific antibodies against Balamuthia to detect the amebas. Finally, a polymerase chain reaction (PCR) molecular assay can detect Balamuthia DNA[5].
However, there are three types  of tests that can help confirm the diagnosis of GAE. The [[indirect immunofluorescence assay]] (IFA) is a test used to detect antibodies attached to Balamuthia amebas in body tissues. In contrast, [[immunohistochemistry]] (IHC) uses specific antibodies against Balamuthia to detect the amoebas. Finally, a [[polymerase chain reaction]] (PCR) molecular assay can detect Balamuthia DNA[5].
 
The [[Centers for Disease Control and Prevention]] (CDC) offers diagnostic assistance for Balamuthia to physicians and scientists through DPDx.


The Centers for Disease Control and Prevention (CDC) offers diagnostic assistance for Balamuthia to physicians and scientists through DPDx.
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 20:57, 4 December 2012

Granulomatous amoebic encephalitis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Granulomatous amoebic encephalitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural history, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Case Studies

Case #1

Granulomatous amoebic encephalitis laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Granulomatous amoebic encephalitis laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Granulomatous amoebic encephalitis laboratory tests

CDC on Granulomatous amoebic encephalitis laboratory tests

Granulomatous amoebic encephalitis laboratory tests in the news

Blogs on Granulomatous amoebic encephalitis laboratory tests

Directions to Hospitals Treating Granulomatous amoebic encephalitis

Risk calculators and risk factors for Granulomatous amoebic encephalitis laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Balamuthia Granulomatous Amebic Encephalitis (GAE) is a serious infection of the brain and spinal cord caused by Balamuthia[1,2,3,4]. GAE is often diagnosed only after death. However, it can be diagnosed by examining blood, cerebrospinal fluid, and tissue samples from a living patient as well. Diagnosis of GAE in a living patient is less common because the amoebas are difficult to identify under the microscope, even with commonly used stains[5].

However, there are three types of tests that can help confirm the diagnosis of GAE. The indirect immunofluorescence assay (IFA) is a test used to detect antibodies attached to Balamuthia amebas in body tissues. In contrast, immunohistochemistry (IHC) uses specific antibodies against Balamuthia to detect the amoebas. Finally, a polymerase chain reaction (PCR) molecular assay can detect Balamuthia DNA[5].

The Centers for Disease Control and Prevention (CDC) offers diagnostic assistance for Balamuthia to physicians and scientists through DPDx.

References


Template:WikiDoc Sources